Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision
Author(s) -
Adi Nosrati,
Jacqueline G. Berliner,
Shilpa Goel,
Joseph McGuire,
Vera B. Morhenn,
Juliana Rocha de Souza,
Yıldıray Yeniay,
Rasnik Singh,
Kristina Lee,
Mio Nakamura,
Rachel R. Wu,
A. Clark Griffin,
Barbara Grimes,
Eleni Linos,
Mary Margaret Chren,
Roy C. Grekin,
Maria L. Wei
Publication year - 2017
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2016.6138
Subject(s) - medicine , wide local excision , mohs surgery , otorhinolaryngology , surgery , melanoma , incidence (geometry) , dermatology , physics , cancer research , optics
Melanoma in situ (MIS) is increasing in incidence, and expert consensus opinion recommends surgical excision for therapeutic management. Currently, wide local excision (WLE) is the standard of care. However, Mohs micrographic surgery (MMS) is now used to treat a growing subset of individuals with MIS. During MMS, unlike WLE, the entire cutaneous surgical margin is evaluated intraoperatively for tumor cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom